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Abstract
Background: Bovine congestive heart failure (BCHF) has become
increasingly prevalent in feedlot cattle in the Western Great Plains of North
America. BCHF is an untreatable complex condition involving pulmonary
hypertension that culminates in right ventricular failure and death. A protein
variant of hypoxia-inducible factor 2 alpha (HIF2α, encoded by the
endothelial PAS domain-containing protein 1 gene, EPAS1) was previously
reported to be associated with pulmonary hypertension at altitudes
exceeding 2,000 m. Our aim was to evaluate EPAS1 haplotypes for
association with BCHF in feedlot cattle raised at moderate altitudes (1,200
m).
Methods: Paired samples of clinical cases and unaffected controls were
collected at four feedlots in Nebraska and Wyoming. Each pair (n =102)
was matched for source, pen, breed type, sex, arrival date, and
management conditions. Cases were identified by animal caretakers,
euthanized, and diagnosis was confirmed at necropsy. Cases were derived
from 30 different ranch operations, with the largest source contributing 32.
Animals were tested for eight EPAS1 haplotypes encoding 36 possible
different diploid combinations.
Results: The common, ancestral EPAS1 haplotype encoding HIF2α with
alanine (A) at position 606 and glycine (G) at position 610 was equally
frequent in cases and controls (0.67). The EPAS1 variant haplotype
reported to be associated with disease (encoding threonine (T) at position
606 and serine (S) at position 610) was not enriched in cases compared
with controls (0.21 and 0.25, respectively). Frequencies of other EPAS1
haplotypes (e.g., encoding Q270, L362, or G671) were each less than 0.05
overall. McNemar’s test with 45 discordant pairs showed the linked
T606/S610 variant was not associated with BCHF (OR = 0.73, CI95 0.38
-1.4, p-value = 0.37).
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Conclusions: HIF2α polypeptide variants were not significantly associated
with BCHF in feedlot cattle at moderate altitudes. Thus, a wider search is
needed to identify genetic risk factors underlying this disease.
Keywords
Heart failure, cattle, EPAS1, HIF2A, brisket disease, pulmonary
hypertension, feedlot
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Introduction
Brisket disease has been known in the Rocky Mountain
Region of Colorado and Utah for more than 100 years as a
high altitude disorder characterized by severe ventral edema of
the chest tissues1,2. In affected cattle, the reduced partial
pressure of oxygen at high altitudes causes pulmonary hypoxia,
vascular resistance, arterial remodeling, and pulmonary hypertension. As late as 1963, reports of brisket disease were limited to cattle grazed at altitudes greater than 2,100 m, with a
prevalence of 2–10%3. This condition, attributed to ‘cor pulmonale’, eventually causes right ventricular overload and enlargement, ultimately leading to heart failure. In 1976, a similar
condition was reported in yearling feedlot cattle maintained at a
lower altitude of 1,600 m4. Since the 1970’s, bovine congestive
heart failure (BCHF) has become increasingly common in feedlot
cattle maintained at the low to moderate altitudes of the North
American Plains (800 to 1,600 m)5. However, it is uncertain
whether hypobaric hypoxia is the underlying cause of BCHF
in these cattle, and evidence suggests that left heart dysfunction may initiate BCHF6. Histopathological assessment of cardiopulmonary tissues obtained from affected cattle fattened at
544–1,420 m revealed significant ventricular fibrosis, abundant
cardiac adipose depots, coronary artery injury, and pulmonary
venous remodeling6. These features were phenotypically distinct from those of cattle with cor pulmonale at high altitudes.
However, other evidence in similarly affected cattle (1,369 m)
suggested death occurred prior to the development of advanced
obesity7. Thus, disease pathogenesis of BCHF in feedlot cattle
maintained at the moderate altitudes remains unclear.
The impact of BCHF on animal mortality is substantial and
appears to be increasing. Mortality in the U.S. and Canada has
been estimated at 11 per 10,000 animals entering feedlots, with
the rate doubling from 2002 to 20125. Personal communication between authors (MPH and BLVL) and a Nebraska feedlot
owner (G. Darnall) in 2018 indicated a BCHF prevalence as
high as 7.5% in some single source lots of cattle. Affected cattle
were typically bred and managed with the aim of achieving high
carcass quality. For some affected producers in the Western
Plains, BCHF is their single most costly health-related problem,
with losses exceeding $250,000 annually in individual operations,
surpassing those from bovine respiratory disease. Consequently,
reducing the impact of BCHF is a high priority for the cattle
industry.
A potential genetic risk factor for BCHF was reported in 2015
for cattle with high-altitude pulmonary hypertension (1,478 to
2,618 m)8. Angus cattle affected with pulmonary hypertension
had a higher frequency of the endothelial PAS domain-containing
protein 1 gene (EPAS1) encoding a hypoxia-inducible factor 2
alpha (HIF2α) double variant with threonine (T) at position 606
and serine (S) at 610. This HIF2α T606/S610 variant was proposed to have a dominant gain-of-function activity8. Subsequent
whole genome sequencing analysis of EPAS1 in 19 breeds of
U.S. cattle identified four additional HIF2α variants encoded by
EPAS1 (E270Q, P362L, A671G, and L701F)9. Together, these
six amino acid variants comprised eight distinct polypeptide
HIF2α sequences. A rooted phylogenetic tree of these HIF2α
protein sequences provided a framework for evaluating their

potential impact on BCHF in U.S. cattle9. In the present report,
our aim was to evaluate EPAS1 haplotypes encoding HIF2α
protein variants for association with BCHF in feedlot cattle,
raised at moderate altitudes. Here we show that the HIF2α T606/
S610 variant encoded by EPAS1 was not associated with BCHF
in feedlot cattle maintained at 1,200 m in the geographic region
experiencing outbreaks. The results are important for understanding the disease mechanism and for future selection of breeding
animals with reduced risk for BCHF.

Methods
Ethical statement
The experimental design and procedures used during this
research project were approved by the Institutional Animal Care
and Use Committee (IACUC) of the University of NebraskaLincoln (UNL) Experimental Outline Number 139. The UNL
animal care program is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, registered
with the United States Department of Agriculture, and assured
by the National Institutes of Health Public Health Service Policy
on Humane Care and Use of Laboratory Animals. The university
meets these goals through review and approval by the IACUC
before projects are initiated for any research and educational
activities involving vertebrate animals, to assure compliance with all
laws, regulations and rules governing the care and use of animals,
and by continuing review and monitoring of approved studies.
No animals were housed at research facilities or cared for by
researchers during this study. All animals were privately owned
and located at commercial feedlot operations and managed
according to their standard operating procedures (SOP),
which includes euthanasia of terminal heart failure cases as
recommended by the American Veterinary Medical Association
(AVMA). All pen matched unaffected (control) animals were
briefly sampled by collecting an ear notch and blood sample
and returned to their pens without further involvement in the
study. In every instance, efforts were made to ameliorate animal
suffering for this incurable, untreatable congesting heart disease.

Animals and study design
Paired samples from 102 affected calves and their 102 unaffected matched penmate controls were collected from four
private commercial feedlots during a 16-month period spanning
January 2017 to April 2018. A sample size of 100 matched pairs
was targeted based on the frequency of the EPAS1 T606/S610
variant in Angus cattle (0.22)9. Together with Hardy-Weinberg
assumptions, the proportion of discordant pairs having one or
two copies of the dominant risk factor was expected to be 0.476
and achieve greater than 80% power to detect an odds ratio of 2.5
using a two-sided McNemar test with a significance level of
0.05 (PASS 2019 Power Analysis and Sample Size Software,
version 19.0.2 (NCSS, LLC. Kaysville, Utah, USA).
Potential clinical cases were identified by experienced animal
caretakers on horseback (pen riders) and segregated for treatment by moving to a hospital pen. This daily activity is part of the
SOP for pen riders, i.e., to identify animals with any potentially
serious health problems and move them to a dedicated treatment
area. Terminal cases were euthanized by feedlot personnel based
Page 3 of 12
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on clinical presentation. Euthanasia was accomplished with
a well-placed bullet by trained feedlot personnel according to
AVMA approved protocols, as part of the feedlot operation’s SOP
for terminally ill animals. The case definition included two or
more clinical signs specific to BCHF: ventral and intermandibular
edema (‘brisket’ and ‘bottle jaw’), jugular vein distention
and pulsation, ascites/abdominal swelling, and exophthalmia
(‘bug-eye’)10,11. The case definition also included two or more
non-specific clinical signs: dyspnea, abducted elbows, depression, drooped ears, intermittent watery orange diarrhea, tachycardia, exercise intolerance, open mouth breathing, and weight loss.
Clinical signs increased with disease progression and in some
cases, animals died naturally within 24 hours of clinical presentation, while other cases progressed over a period of days to
weeks, and thus provided a window of opportunity to collect
fresh samples immediately after euthanasia. Researchers were
contacted by the feedlot operator when an animal became ill and
needed to be euthanized. Researchers then travelled to the feedlot for sample collection. A presumptive diagnosis based on
heart morphology and gross lesions was made at necropsy by
animal caretakers (cases one to nine) and veterinarians (cases 10
to 102). Carcasses were enrolled in the study only if there was a
postmortem presumptive diagnosis of congestive heart failure
at necropsy.
Control tissue samples were collected from non-affected
penmates matched for source, arrival date, gender, and breed type
(based on source, coat color, horned/polled status, ear size and
dewlap). The pen sizes ranged from 100 to 300 animals, and
control animals were selected based on their willingness to be
driven through the gate by riders on horseback. In two instances,
the same control animal was inadvertently used as a penmate match
for two clinical cases. None of the control animals developed
clinical BCHF signs prior to harvest according to feedlot
records and pen rider observations.
Tissue samples for genomic DNA isolation included V-shaped
ear notches and EDTA whole blood collected by venipuncture.
Squeeze chute devices at the feedlot facilities were used for
sample collection with animals that were able to safely enter and
exit the gates. Some affected animals were not able to safely enter
the device and thus, their samples were collected immediately
after euthanasia. The ear tissue was desiccated with granular
NaCl in the field and stored at -20°C upon return to the research
facility (four to twelve hours later). The plasma and cellular
fractions of EDTA whole blood were separated in the field by
centrifugation for 10 minutes at 1,350 x g, placed in liquid
nitrogen immediately and stored at -80°C upon return. Hearts,
livers, blood, and ear notches from unaffected cattle were
collected during federally-inspected beef processing at the
U.S. Meat Animal Research Center abattoir from six purebred
Angus heifers raised and fattened at 578 m and 15 purebred
Angus cows maintained for breeding at 578 m.

DNA extraction and single nucleotide polymorphism (SNP)
genotyping
Unless otherwise indicated, reagents were molecular-biology
grade. DNA from ear notches was extracted by standard

procedures12. Briefly, hair follicles were shaved from the tissue
and approximately one half of the ear notch was minced and suspended in 2.5 mL of a lysis solution containing 10 mM TrisCl,
400 mM NaCl, 2 mM EDTA, 1% wt/vol sodium dodecyl
sulfate, RNase A (250 ug/ml; Sigma-Aldrich, St. Louis, Missouri,
USA), pH 8.0. The solution was incubated at 55°C with gentle
agitation. After one hour, 1 mg proteinase K was added (SigmaAldrich) and the solution was incubated overnight at 55°C with
continued agitation. The solution was transferred to a 15 ml
tube containing 2 ml of a phase-separation gel (high-vacuum
grease, Dow Corning Corporation, Midland, Michigan, USA)
and extracted twice with one volume of phenol:chloroform:isoamyl alcohol (25:24:1), and once with one volume of chloroform
before precipitation with two volumes of 100% ethanol. The precipitated DNA was washed once in 70% ethanol, briefly air dried,
and dissolved in a solution of 10 mM TrisCl, 1 mM EDTA (TE, pH
8.0). A single multiplex matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS) assay was
used for the six EPAS1 missense SNPs, as previously described9.
Assay design and genotyping was performed at Neogen GeneSeek
Operations (Lincoln, Nebraska, USA). The iPLEX Gold technology and MassARRAY DNA analysis system with MALDI-TOF
MS (Agena Biosciences Inc., San Diego, California) was used
according to the manufacturer’s protocol. Briefly, genomic DNA
was amplified in microtiter plates using the supplied reagents.
After the PCR, excess nucleotides were dephosphorylated by
shrimp alkaline phosphatase. This was followed by a single base
extension reaction in which a mix of oligonucleotide extension
primers was added together with an extension enzyme and massmodified dideoxynucleotide terminators. The extension primers are designed to anneal directly adjacent to each SNP site and
were extended and terminated by a single complementary base.
The extension products were desalted and transferred from the
microtiter plate onto a chip array, where they crystalize with a
pre-spotted MALDI matrix. The chip array was loaded into the
mass spectrometer, where the analyte crystals were irradiated by
a laser, inducing desorption and ionization. The positively charged
molecules accelerate into a flight tube towards a detector. Separation occurs by time-of-flight, which is proportional to the mass
of the individual molecules. After each laser pulse, the detector
records the relative time of flight for each extension product
and the results were displayed on the machine. Genotypes were
scored automatically and summary reports were generated.

Assigning haplotype phase and statistical analyses
As previously reported, a maximum parsimony phylogenetic
tree was used to unambiguously phase protein variants encoded
by EPAS1 haplotypes9. Haplotype-phased protein variants were
unambiguously assigned in individuals that were either:
1) homozygous for all six variant sites, or 2) had exactly one heterozygous variant site. The phylogenetic tree was also important
for providing a framework for chi-squared testing. The association of EPAS1 haplotype combinations (diplotypes) with clinical
disease was evaluated with two tests. The first was a Pearson’s
chi-squared test since it met requirements for appropriate use:
nominal categorical data, large sample size (n = 204), and
independence of observation assumption (cases were mutually exclusive of controls). There was a small deviation of the
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assumption that each subject contributes to one and only one
cell, because two of the control animals were each inadvertently
drawn twice from their pen. None of the animals classified as
controls developed clinical disease prior to harvest. A 2 x 4
contingency table was used to test the four diplotypes combinations represented by at least ten animals13. The second evaluation
for association of the EPAS1 T610/S610 variant with clinical
disease was McNemar’s test for correlated proportions14. This
is the most appropriate test for paired nominal data.

Results
The 102 clinical BCHF cases and their penmate controls
originated from 30 different sources, with the largest single source
contributing 32 matched pairs (Table 1 and S1, see Underlying
data). Although breed information was not available for many
animals, the pairs were comprised of 100% polled, 93% solid
black, and 70% male calves (Table S1, see Underlying data).
Most of the 102 calves were from known, well-managed herds
that focus on using Angus genetics. Clinical cases of BCHF were
documented throughout all stages of calf fattening regimens
(Figure 1). The most consistent signs at necropsy included:
ventral and intermandibular edema, dilated pulmonary artery
and right ventricle, and chronic passive congestion of the liver
(Figure 2). The success of identifying BCHF cases was entirely
dependent on highly trained, experienced pen riders. The false
positive rate for pen rider-identified BCHF cases confirmed at
necropsy was zero at sites NE01, NE04, and WY01; and 50% at
WY02 (three cases from six suspected cases). Together, samples
from the 102 matched case-control pairs represent a resource
for evaluating genetic, biochemical, and physiological questions
about the mechanism of BCHF in feedlot cattle.

DNA samples from cases and controls were tested for association with known EPAS1 haplotypes according to the phylogenetic
framework presented in Figure 3. Haplotype-phased protein
variants (diplotypes) were unambiguously assigned for 98.5% of
the animals (201/204, Table S1, see Underlying data). The frequency of the common, ancestral EPAS1 haplotype (‘1’) was
nearly identical in the cases and controls (0.67). The T606/S610
variant reported to be dominantly associated with high-altitude
pulmonary hypertension (haplotype ‘3’) was less frequent in the
cases (0.21) than the controls (0.25, Table 2). In addition, there
was no statistical difference between four common diplotypes
among the cases and controls in a Pearson’s chi-square analysis (Table 3). However, the appropriate statistical test for paired
nominal data is McNemar’s test. This test with 45 discordant pairs
showed the T606/S610 variant was not associated with BCHF
(Table 4, OR = 0.73, p-value = 0.37, CI95 0.38 -1.4). With 0.44

Table 1. Feedlot sites and sources for
case-control pairs.
Sitea

Altitude m (ft)

Pairs

Sources

NE01

1,242 (4,075)

76

19

NE04

1,163 (3,816)

17

9

WY01

1,263 (4,143)

6

1

WY02

1,280 (4,198)

3

1

Totals

102

30

NE and WY sites were located in Nebraska and
Wyoming, respectively
a

Figure 1. Bovine congestive heart failure (BCHF) clinical cases at different stages of fattening. Three types of animals identified by
feedlot pen riders as end-stage heart failure candidates. Clinical cases were born and raised at 1,000 to 1,200 m prior to feedlot arrival. Their
respective heart gross morphologies with enlarged right ventricles and pulmonary arteries are shown below each case. The control heart is
from an Angus heifer fattened at 550 m.
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Figure 3. Physical map and rooted maximum parsimony
phylogenetic tree of HIF2α protein variants (EPAS1 haplotypes).
Panel A, map of bovine HIF2α domains in relationship to missense
mutations found in cattle: bHLH, basic helix-loop-helix domain;
PAS-A and PAS-B, Per-Arnt-Sim domains; ODDD, oxygendependent degradation domain; N-TAD, N-terminal transactivation
domain; C-TAD, C-terminal transactivation domain. Panel B, HIF2α
polypeptide sequences encoded by haplotype variants. The areas
of the circles are proportional to the variant frequency in a group of
1,250 cattle from 46 breeds with each node in the tree representing
a different polypeptide sequence of HIF2α that varies by one
amino acid compared to adjacent nodes. Reproduced from Heaton
et al., 20169.
Table 2. EPAS1 haplotype frequencies among cases
and controls.
Allele frequencies
Haplotype
code
Figure 2. Gross morphological differences of a heart and liver
in a representative bovine congestive heart failure (BCHF)
clinical case. Panel A, affected heifer from (pair 77, Table S1)
fattened at 1,200 m. Panel B, Gross heart morphology of affected
heifer from pair 77 (left) and an unaffected Angus cow maintained
for breeding at 578 m (right). The dashed line denotes where each
heart was sectioned to show the dorsal half. Abbreviations: RV, right
ventricle; LV, left ventricle; PA, pulmonary artery. Panel C, crosssection of the respective livers.

Distinguishing
Feature

Cases

Controls

1

Ancestral

0.667

0.672

2

Q270

0.059

0.034

3

T606, S610

0.206

0.250

4

L362

5

-a

-

Q270, L362

0.005

0.020

6

G671

0.064

0.025

7

F701

-

-

Not detected

a
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Table 3. Pearson’s chi-squared analysis of EPAS1 diplotypes among cases
and controls.
EPAS1 diplotypea
1,1

1,2

1,3

1,6

Disease status

Obs.

Χ

Obs.

Χ

Obs.

Χ

Obs.

Χ2

Totals

Affected

43

0.05

11

0.67

30

0.34

8

1.07

92

Unaffected

45

0.05

6

0.69

36

0.35

3

1.09

90

Totals

88

b

2

17

2

2

66

11

182

Diplotypes not shown had less than ten total observations and thus were omitted from the
analysis.
a

b

The chi-square statistic was 4.3 and the p-value was 0.23.

Table 4. McNemar’s test with EPAS1 T606/S610
and Q270 variants.
Risk factor presenta
Matched pairsb

T606/S610

Q270

Case (1), Control (0)

19 pairs

10 pairs

Case (0), Control (1)

26 pairs

5 pairs

Odds ratio

0.73

2.0

p-value

0.37

0.30c

95% CI

0.38 - 1.4

0.62 - 7.4

c

The risk factor was defined as having one or two copies
of the EPAS1 variant.
a

The ‘(1)’ and ‘(0)’ indicate the presence or absence of
the risk factor, respectively.
b

The p-value is the probability of observing this
distribution of discordant pairs if there was no
association between risk factor and disease.
c

discordant pairs having the T606/S610 variant, the sample size of
102 pairs achieved 80% power to detect an odds ratio of 2.5 using a
two-sided McNemar test with a significance level of 0.05.
Frequencies of three other EPAS1 haplotype variants (Q270, L362,
and G671) were less than 0.05 and too rare to analyze with a
McNemar test. Thus, an association with EPAS1 haplotype
variants was not detected with BCHF in these cattle.

Discussion
The present report describes a set of 102 clinical cases of
BCHF and their matched controls collected from U.S. feedlots where outbreaks were severe and ongoing. Genetic analyses
of EPAS1 variants did not show an association with BCHF. This
result was significant because cases were closely matched with
unaffected penmate controls from the same source, sex, breed
type, arrival date, and management conditions. In some pairs,
ear tag information suggested that animals shared the same sire.
Case-control studies are a common and efficient means of
studying diseases with a low prevalence and the McNemar’s

test is the appropriate statistical test for use on paired nominal
data15. A major advantage of the present design was the ability to increase the frequency of a potential genetic risk factor
with relatively few participants (102 cases), while still evaluating more than 10,000 animals per feedlot site for disease.
Nevertheless, results presented here suggest it is unlikely that
genetic variation at the EPAS1 locus was a significant genetic risk
factor for BCHF in these cattle.
The lack of EPAS1 association with BCHF is inconsistent with that reported in 2015 by Newman et al. for cattle with
high-altitude pulmonary hypertension8. However, there were
important differences in the cattle types, age, environment, and
clinical definitions between the two studies. Animals in the 2015
study were mature, pastured cattle, maintained at 1,478 to 2,618 m,
and had pulmonary arterial hypertension, as measured by heart
catheterization. In the present study, animals were yearling steers
and heifers, raised and fattened at approximately 1,200 m, and had
end-stage heart failure. Thus, it is possible that the animals
in these respective studies are suffering from similar but different
diseases. Another possibility is the cattle described by Newman
et al. were affected by a right-sided ventricular heart failure initiated by hypobaric hypoxia, whereas the cattle in the present
study had a left-sided ventricular failure, resulting in tissue
hypoxia and subsequent BCHF. The latter was reported in 2019
in cattle fattened at 1,200 m suffering end-stage heart failure6.
However, it is unknown whether the disease pathogenesis was a
distinguishing factor in these studies. One remarkable feature of
the BCHF clinical cases in the present study were those displaying signs of the disease at feedlot arrival and soon after. This is
consistent with the hypothesis that fattening is not the
underlying cause of disease in these cattle.

Conclusions
Protein variants encoded by EPAS1 haplotypes were not
significantly associated with BCHF in fattened cattle at moderate altitudes in the North American Western Plains. Thus, identifying the genetic risk factors underlying this form of the disease
may require a wider search.
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Data availability
Underlying data
Figshare: Table S1. Metadata and phased EPAS1 diplotypes
for 102 case-control pairs. https://doi.org/10.6084/m9.figshare.
8862089.v116

Extended data
Figshare: Table S2. Summary of 36 possible EPAS1 diplotypes
and their frequency in cases and controls. https://doi.org/10.6084/
m9.figshare.8862152.v117
Figshare: Table S3. EPAS1 haplotype frequencies in cases and
controls. https://doi.org/10.6084/m9.figshare.8862179.v118
Figshare: Table S4. EPAS1 risk factor scoring used in
McNemar’s Test with 102 matched pairs. https://doi.org/10.6084/
m9.figshare.8862200.v119
Data are available under the terms of the Creative Commons
Zero “No rights reserved” data waiver (CC0 1.0 Public domain
dedication).
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Similarly for “Control tissue samples were collected from non-affected penmates”, was this just ear
tissue as mentioned in the methodology or other tissues, which could be used for RNA-Seq and
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“Hearts, livers, blood, and ear notches from unaffected cattle were collected during
federally-inspected beef processing at the U.S. Meat Animal Research Center abattoir from six
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breeding at 578 m.” It needs to be clear from this sentence that these were for visual and gross
morphological comparison with affected BCHF organs, as this only becomes obvious in Figure 1.
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the authors.
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